SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-16-807385
Filing Date
2016-12-29
Accepted
2016-12-29 16:47:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D AMENDMENT NO. 1 d263105dsc13da.htm SC 13D/A 24376
  Complete submission text file 0001193125-16-807385.txt   25809
Mailing Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850
Business Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850 3019613400
Sucampo Pharmaceuticals, Inc. (Subject) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-83614 | Film No.: 162075603
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1623 28TH STREET, N.W. WASHINGTON DC 20007
Business Address 1623 28TH STREET, N.W. WASHINGTON DC 20007 202-298-6007
S&R Foundation (Filed by) CIK: 0001614000 (see all company filings)

IRS No.: 522284478 | State of Incorp.: DC | Fiscal Year End: 1231
Type: SC 13D/A